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Abstract 
Background: Although dental implant therapy is considered a predictable treatment modality 
with reported high survival and success rates, biological complications do occur, and a number 
of risk factors have been involved. Tobacco smoking is related to many health risks affecting 
general & oral health. 
Objectives: The aim of this systematic review and meta-analysis is to test the null hypothesis of 
no difference in dental implant failure rates and marginal bone loss between smokers and non-
smokers with regards to follow-up time. 
Search methods: An extensive electronic search was performed in PubMed, Scopus and 
EBSCOhost Dentistry and Oral Sciences source to identify relevant articles published up to June 
2019. The eligibility criteria included randomized and non-randomized clinical trials & 
prospective & retrospective observational studies. After a thorough selection process, 23 papers 
were included. The meta-analysis was expressed in terms of the odds ratio (OR) or standardized 
mean difference (SMD) with a conﬁdence interval (CI) of 95% and the level of statistical 
signiﬁcance was set at P < 0.05. 
Results: There was a statistically signiﬁcant difference in marginal bone loss favoring the non-
smoking group with a SMD of 1.07 (95% CI 0.67–1.48), demonstrating a statistically signiﬁcant 
difference in favor of non-smokers (P<0.00001). A subgroup analysis in smokers revealed a 
statistically significant increase in marginal bone loss in the maxillary implants compared to the 
mandible (P = 0.008) with a SMD of 1.39 (95% CI 0.35–2.42) although with a high level of 
heterogeneity (I2 = 97%; P = 0.0001). A statistically signiﬁcant difference (P < 0.00001) in 
implant failure rate in favor of the non-smoking group was also observed, with OR of 2.24 (95% 
CI 1.90–2.64). Moreover, the subgroup analysis for follow-up time revealed a signiﬁcant 
increase in implant failure proportional to the increase in follow-up time (P = 0.05), but with 
considerable heterogeneity (I2=74.5%). 
Author’s conclusion: Based on the results of this review, the null hypothesis is rejected, and that 
is in agreement with other reports in the literature. Therefore, the clinical recommendation for a 
period of abstinence from smoking that at least covers the pre-surgical evaluation & initial 
therapy, definite implant treatment & immediate post-op phases remains to be very relevant. 
Keywords: edentulous, partially edentulous, smoking, tobacco use, dental implants, bone 
resorption, marginal bone loss, failure rate, cumulative survival rate. 
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Review of pertinent literature 
Methods of evidence-based dental practice was introduced to optimize the decision-making 
processes in diagnosis and treatment planning, and for comprehensive patient information in 
preparation of diagnostic and therapeutic interventions, particularly before elective procedures. 
Outcome anticipation is an important aspect of risk management in contemporary implant 
dentistry. Recognizing the factors that may potentially place the patient receiving dental 
implant(s) at a higher risk of implant failure or other adverse conditions allows the practitioner to 
make informed decisions and reﬁne the treatment approach to optimize the results and improve 
the predictability of successful therapy.59 As in other topics, RCTs are one of the most reliable 
sources of information for clinical practice and therefore are the studies preferred for the 
elaboration of longitudinal studies in implant dentistry.73 However, the inclusion of longitudinal 
observational studies, with high number of participants can potentially increase the amount of 
viable data. The Early longitudinal studies evaluating osseointegrated dental implants showed 
satisfactory results.65,66 Currently, with more than 40 years of scientiﬁc evidence, the clinical use 
of dental implants has been increasing day by day. Nevertheless, few studies have examined 
follow-up periods for ten years or longer, which is important to enable us to understand the 
biological aspects of dental implant therapy.136 Implant-supported prostheses have been shown to 
have successful long-term outcomes.19,31,32,83, 91,94 However, numerous local and systemic factors 
have been hypothesized to affect implant success to various degrees.59,69,160 Such factors include 
but are not limited to implant insertion in type III and IV bone qualities,50 reduced initial stability 
of the implant, particularly in cases of immediate loading protocol, implant placement in 
posterior maxilla, radiation therapy sites, drug and alcohol intake, and tobacco smoking. When a 
cause-effect relationship is being investigated, an accurate definition of the potential cause is 
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imperative. This is particularly important when the effect is expected to be frequency and dose 
dependent. In the medical literature, smoking was established to cause a dose-dependent effect 
on the extent of bone loss and the risk of fracture in long bones.167 Surprisingly, however, 
smaller doses of nicotine have been found to stimulate osteoblastic growth.98 Wide variations in 
the definition of smoking are encountered in the dental literature in terms of smoking duration, 
number of cigarettes consumed daily, and categorization of previous smokers, and these 
variations prevent a detailed analysis of the predictability of measure outcomes. Different patient 
and implant-related confounding factors have been shown to impact the clinical outcomes 
associated with dental implants, but these factors are not always considered in the included 
studies. Many studies investigated the correlation between tobacco smoking and adverse 
implant-related outcomes, some align with the hypothesis that tobacco smoking increases 
implant failure rate, but others does not reach the same conclusion.6,49,120,159 Currently, no 
consensus has been reached, and no evidence-based guidelines have been generated to help 
clinicians make informed clinical decisions in utilizing dental implant treatment in tobacco 
smokers. These shortcomings may be attributed to several factors, like the variability in the 
design, quality and findings of studies conducted. The considerable heterogeneity among the 
studies has made direct comparison across studies a difficult task. Therefore, there is a limited 
number of recent systematic reviews comparing dental implant complications in smokers to non-
smokers. Peri-implant mucositis is the most common biological complication associated with 
dental implants.73,144 It is characterized by a reversible inﬂammatory process, demonstrating a 
color change and redness and bleeding of the peri-implant mucosa, without presenting signs of 
bone resorption. Probing of the peri-implant sulcus and identifying signs such as the presence of 
bleeding or suppuration is important for thorough diagnosis of implant health,173 particularly 
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peri-implant mucositis. Clinically, peri-implant probing depth is inﬂuenced by a number of 
factors, including the depth of implant placement, the level of peri-implant marginal bone, peri-
implant soft tissue phenotype and thickness, type of the prosthetic abutment, emergence proﬁle 
of the prosthetic restoration, the region in which the implant was placed.114 Probing depths of 
>=5 mm must be investigated, as they may be indicative of peri-implant disease. However, peri-
implant probing depths were either unreported or reported with wide variations with regard to the 
exact probing depth value in millimeters or the numbers of sites probed per implant. Therefore, 
the author elected not to select peri-implant probing depth as an outcome variable in this review. 
Ever since the ﬁrst longitudinal studies were conducted to evaluate the clinical performance of 
implants,65,66 various authors have proposed different criteria for classifying implant health and 
success. Nonetheless, up to the current time, no standardization for this classiﬁcation has been 
made in the literature and that leads to considerable difﬁculty in the interpretation and 
comparison of data among the available studies. Due to the differences in criteria adopted by 
different authors, it is not always possible to arrive at an absolute mean value for the success 
rates in systematic reviews. However, in two systematic reviews by Needleman et al (2012)130 
and Papaspyridakos et al (2012)134 evaluating the success criteria for implants, the criteria of 
Albrektsson et al. (1986)68 were related in around 33.3% (n = 78) and 31.7% (n = 41) of the 
studies included, respectively. This demonstrates that these remain to be the most widely 
accepted criteria at the present time. In longitudinal studies on osseointegrated dental implants, 
the terms ‘survival’ and ‘success’ are routinely used. However, these terms continue to generate 
confusion regarding their actual meanings154 and are frequently used incorrectly. Knowledge and 
standardization of these terms is necessary to facilitate communication, comparison, and 
thorough understanding among dental professionals.48,73,153,158 Studies evaluating success rates in 
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implant dentistry are complex because of the large number of confounding variables, such as 
surgical techniques, materials used, and follow-up period. In addition, several criteria have been 
proposed for the deﬁnition of success48,62,68,109,143,147,153,172 and the absence of international 
standardization makes it rather difficult to compare studies.130,153 While other authors have 
argued that a period of 5 years may still be too short to enable reliable information to be 
obtained,107 a minimum of 5 years of follow-up is necessary130,137 to properly analyze survival 
and success rates of dental implants. The majority of longitudinal studies evaluated only the 
survival rate of dental implants, as a quantitative analysis, potentially underestimating the 
importance of the data with reference to the overall health and quality of the placed implants. 
The most probable reason for the preference for survival studies appears to be related to easier 
methodology for that analysis;153 i.e. the measurement for statistical analysis is done only by 
counting the implants remaining in situ. Conversely, evaluating dental implant success involves 
analysis of more complex parameters and criteria and is more directly associated with the health 
and quality of the implants. Consequently, the statistical differences between the survival and 
success rates are typically signiﬁcant. Smoking has been shown to be a primary risk factor for 
general health and responsible for many serious diseases, as for 90% of all lung cancers, 70% of 
chronic lung diseases, 80% of myocardial infarctions before the age of 50, and 30% of chronic 
ischemic heart diseases and strokes.51,52,53 There are an estimated 1.3 billion smokers around the 
world, and 4.9 million people die from tobacco smoking-related diseases every year (WHO).174 
Besides the general role healthcare professionals play in tobacco smoking cessation and 
prevention, certain aspects pertaining to modern dental implant practice should be considered in 
tobacco smokers for thorough patient evaluation before oral surgical procedures and implant 
treatment planning. While the smoking cessation and sustained abstinence well before oral 
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surgical procedures should be the ultimate goal, nicotine dependence has proven to be a chronic 
relapsing disorder and is usually characterized by multiple failed quitting attempts.129 
Nevertheless, a number of studies have suggested that adjunctive measures can possibly 
minimize the negative effects of tobacco smoking on dental implant survival rates.70,77 
Abstinence from smoking for one week before and eight weeks post implant placement has been 
reported to improve the success rate associated with the Branemark implants.70 Opting for a two-
stage placement and delayed loading protocol with may minimize the accumulation of bacterial 
biofilms and the diffusion of several of the nearly 4000 chemicals contained in cigarette 
smoke.35,162 Placement of dental implant in special populations like tobacco smokers requires 
consideration of the potential beneﬁts to be gained from the treatment and possible adverse 
effects. To better appreciate this potential, properly conducted, high-quality systematic reviews 
and meta-analysis, whenever possible, comparing the survival rate of dental implants, 
postoperative infection, and peri-implant marginal bone loss (MBL) between smokers and non-
smokers are essential to critically summarize the current knowledge and synthesize evidence. 
Thorough patient information not only about the planned treatment approach and the expected 
outcomes, but also about risks and risk factors are necessary to support the patient’s decision 
making before dental implant therapy.155 Moreover, smoking cessation advice, given in 
conjunction with dental health information may have a marked effect on smokers’ attitude 
toward their habit and provide a powerful incentive to reduce or even quit smoking.125 When 
placing dental implants in smokers, the peri-operative use of antibiotics96 as well as additional 
local potential preventive measures, like using ﬂat instead of high cover screws, should be 
considered in an attempt to prevent postoperative complications during the healing period.18 
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Recombinant human parathormone (PTH 1-34), which is an anabolic agent approved for the 
treatment of patients with osteoporosis that stimulates osteoblast function,92 has been reported to 
increase bone volume around implants in the presence of cigarette smoke in animals.119 It is 
strongly suggested that the direct exposure of the peri-implant tissues to tobacco smoke products 
is the main factor causing an increase in dental implant failure rate in smokers compared to non-
smokers.104 The increased risk of post-surgical wound healing complications105,126,127,146 as well 
as the risk of peri-implant marginal bone loss and increased implant failure rates10,116,121 must be 
emphasized. Delayed wound healing has to be anticipated due to deficient collagen synthesis and 
production,106 reduced peripheral blood circulation and capillary bed perfusion115 and 
compromised polymorpho-nuclear leucocytes and macrophages functions.110,124 Furthermore, 
tobacco smoking was indicated as a signiﬁcant subject-based risk factor for periodontitis in 
literature reviews.132,139 Although not entirely understood, the long-term chronic effect of 
smoking on periodontitis was found to be due to impairment of periodontal tissues vasculature 
through vasoconstrictive effects at the end-arterial gingival vessels,54 multiple function 
deficiencies of fibroblasts and neutrophils and reduced inﬂammatory response.132 Therefore, a 
regular and strict recall of smoking patients undergoing implant treatment is important for early 
detection of implant complications. The carbon monoxide generated during combustion of 
tobacco smoking lowers the oxygen tension in tissues by displacing the oxygen from 
hemoglobin.117 Nicotine, which has been found in high concentrations in saliva101,103 and 
crevicular fluid84 of smokers has been reported to have a negative impact on bone regenerative 
capacity.71,161 Furthermore, polymorphonuclear neutrophils viability, opsonization & 
phagocytosis are significantly reduced in smokers compared to non-smokers.110 Nicotine is the 
most significant constituent among more than 4000 potentially harmful substances in tobacco 
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products. It is the principal chemical component that causes tobacco addiction, appears to 
mediate the vasoconstrictive effects of tobacco smoking, and involved in the pathogenesis of 
many diseases.80 The exact mechanism by which tobacco smoke affects the osseointegration 
process remains to be unclear. However, several chemicals found in tobacco smoke have been 
shown to reduce the vascularity of the peri-implant tissues, and so may compromise the bone 
healing process.132 Approximately 3 mg of nicotine and 20–30 mL of carbon monoxide is 
inhaled for each cigarette smoked.151 Nicotine has been related to increased platelet aggregation 
and interference with the function of fibroblasts, osteoblasts, red blood cells and 
macrophages.55,81,102,164,169 In addition, carbon monoxide converts hemoglobin into 
carboxyhemoglobin rather than oxyhemoglobin due to its 200-fold greater affinity for 
hemoglobin than oxygen. The formation of carboxyhemoglobin decreases oxygen transportation, 
resulting in reduced tissue oxygenation and hypoxia.72,106,117,131,140 Although tobacco smoking is 
widely accepted as a risk factor for oral health in general,54 smoking was considered a risk factor 
for implant treatment since the ﬁrst publication on this topic by Bain & Moy (1993).3 
Nevertheless, the impact of consideration of the patient’s status as a smoker or non-smoker in 
dental implant treatment planning seems to be uncontroversial, but indistinct. In 1999, a national 
survey questionnaire to National Health Service (NHS) consultants evaluating their attitudes 
regarding medical and oral health-related factors considered in patient selection and treatment 
planning for dental implant placement revealed that, among others, tobacco smoking was one of 
the most important factors contraindicating dental implant therapy.75 Another survey among 
Finnish dentists to evaluate the relationship of various patient characteristics or possible 
contraindications for dental implant therapy revealed that more dentists practicing in the public 
or private sectors recommended implant therapy compared to staff of dental schools in case of 
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smoking patients. Older dentists (40–49 years) were found to be more in favor of implant 
treatment in smoking patients than younger dentists (30–39 years).99 Therefore, validation of 
smoking as a risk factor in treatment decisions may differ among dentists. This impression seems 
to be conﬁrmed by different attempts made to quantify the number of cigarettes smoked per day 
in different studies. Human and animal studies have showed the deleterious effects of tobacco 
smoking on the health of oral tissues. Animal studies86,123 have demonstrated that nicotine 
inhibits gene expression of several enzymes that play an important role in the regulation of 
osteoblast proliferation, differentiation and apoptosis, subsequently affecting bone formation and 
remodeling. Furthermore, it was shown that exposure to nicotine has a direct effect on blood 
vessels, producing vasoconstriction which decreases blood perfusion and causes low oxygen and 
local ischemia.122,166 In addition to delivering oxygen and nutrients to tissues, blood circulation 
plays an active role in bone formation and remodeling by mediating the interactions between 
different bone and vascular cells at different regulatory levels.93 In a clinical study (AlBandar et 
al. 2000),67 tobacco smokers had a higher prevalence of moderate and severe periodontal disease 
with increased attachment loss and gingival recession compared to non-smokers, indicating 
worse periodontal conditions in the smokers’ group. Furthermore, smokers had more missing 
teeth than non-smokers. Several review articles identiﬁed within this literature search conﬁrmed 
that smoking is one of the factors related to implant failure by reporting conclusions of several 
studies showing that smoking is associated with higher failure rates, complications and altered 
peri-implant tissue conditions.54,87, 88,149,170 A literature review by Klokkevold and Han (2007)113 
suggested that tobacco smoking may be a signiﬁcant risk factor with an adverse effect on implant 
survival and success rates in areas of lower jawbone quality but may not be as signiﬁcant in sites 
with better bone. While a review by Levin and Schwartz-Arad (2005)49 revealed a signiﬁcant 
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association between smoking, peri-implant marginal bone loss, reduced survival rate of implants 
(0.001 < p < 0.05) and the outcome of onlay bone grafts (p < 0.05) as well.  In a recent meta-
analysis (Chen et al 2013),78 smoking was associated with an increased risk of dental implant 
failure. However, the analysis did not investigate the effects of tobacco smoking on peri-implant 
MBL. Results from another meta-analysis (Chrcanovic et al. 2015),60 suggested that insertion of 
dental implants in smokers affected implant failure rates, the risk of postoperative infection, and 
peri-implant MBL. It is hypothesized that the increased implant failure rates in tobacco smokers 
are mainly due to smoking effect on osteogenesis and angiogenesis. The commercially available 
titanium used in dental implant manufacturing have a wide range of surface topographies or 
morphologies and chemical and physical properties depending on how it is prepared and 
handled, examples include turned, acid-etched, sandblasted and acid-etched, sandblasted and 
ﬂuoride-modiﬁed, and oxidized dental implants.56,57,58 It is known that the surface modifications 
of different dental implant brands influence the osseointegration process.168 A retrospective 
cohort study by Balshe and colleagues (2008)27 reported that smoking was not signiﬁcantly 
associated with implant failure among the moderately rough surface (anodized) implants, while it 
was associated with implant failure among the group with minimally rough surface implants. 
Despite the large number of implants in this study (n = 4607), the results were not included in the 
upcoming meta-analysis because the number of placed and the number of failed implants were 
not separately reported between smokers and non-smokers. The evidence presented by Balshe et 
al.27 did not meet all requirements to be included in the current meta-analysis, however it is a 
valuable addition to the literature due to the great number of implants investigated. In a more 
recent study by Sayardoust et al. (2013),16 turned implants had more peri-implant MBL and a 
higher incidence of failure in smokers, while oxidized implants showed similar MBL and failure 
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rates in smokers and non-smokers. Such contrasting results indicate that controversy still exists 
and that there is a need for additional studies to investigate the long-term outcomes of implants 
with altered surface characteristics in tobacco smokers.113 The studies included in the current 
analysis used implants with several different brands and surface characteristics. In a retrospective 
study investigating success rates of dental implants placed in grafted maxillary sinuses, Kan et al. 
(1999)108 reported a 93.04% success rate in non-smokers and an 82.82% in smokers. In another 
study by the same authors175 with a longer follow-up period, the success rate for the non-smokers 
was 82.7% and for smokers was 65.3%. Therefore, in considering the difference in success rates 
in smokers and non-smokers for implants placed in loose trabecular bone sites that are followed 
over a longer period of time, the adverse effect of smoking may become more evident. A longer 
follow-up period can lead to an increase in the failure rate, particularly if it extended beyond 
functional loading, because other restorative factors can inﬂuence implant failure after loading. 
This may project an underestimation of actual failures in some clinical studies. However, it is 
difficult to deﬁne what would be considered a short follow-up period to evaluate implant failure 
rate in smokers. Results from the meta-analysis by Chrcanovic et al. (2015)60 demonstrated that 
smoking is associated with increased number of dental implant failures regardless of the type of 
implant surface topography or modification. Additionally, a higher risk ratio was observed with 
rough-surface implants compared to turned implants in the smoking group. Nevertheless, there is 
some contradictory evidence that smoking is associated with older turned implant surfaces but 
not with modern ones. With regard to the bone-implant interface, the detrimental effects of 
tobacco smoke have a series of local and systemic influences on bone metabolism.135 Concerning 
associations with patients’ tobacco smoking status, peri-implant bone level is known to be 
associated with implant prognosis.61,74,82,143,148,149 The peri-implant marginal bone around the 
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implant platform is normally a signiﬁcant indicator for deﬁning good peri-implant health. Misch 
et al. (2008)48 classiﬁed the implants with marginal bone loss of <2 mm from the time of initial 
surgery as successful, while according to Albrektsson and Isidor (1993)62 an implant is regarded 
as successful when it presents bone resorption of less than 1.5 mm in the ﬁrst year after 
prosthetic loading and 0.2 mm in subsequent years. Other authors147 have proposed that an 
implant should present a lower bone resorption than one third of the implant length, regardless of 
the number of years in function. To date, there is no consensus regarding the quantity of peri-
implant marginal bone resorption consistent with time after placement, overall health, and 
success. In a recent meta-analysis by Alfadda (2018),33 smokers experienced significantly more 
implant failure and peri-implant marginal bone loss relative to nonsmokers. These findings are in 
accordance with those of another review conducted by Moraschini et al. (2016).35 The greater 
difference in MBL observed between smokers and nonsmokers in association with aging (~0.02 
mm/year) may be explained by a combination of the depleting effect of the tobacco chemicals on 
bone vascularity and the slow, progressive, age-related phase of bone loss in trabecular and 
cortical bone.97,111,141 A meta-analysis by Strietzel et al. (2007)156 on studies in which threaded 
titanium implants with machined, titanium plasma sprayed (TPS) or Hydroxyapatite (HA)-coated 
surfaces were predominantly used, revealed a signiﬁcantly enhanced risk for implant failure 
among smokers compared to non-smokers. The study compared the implant related odds ratios 
for implant failure in smokers considering different observation periods. The risk of implant 
failure for smokers ranged from 2.8 after up to 1 year decreasing to about 2.3 up to 5 years, 
indicating a higher risk of early implant failure. However, the risk of implant failures in smokers 
was found to be signiﬁcantly increased even after 5 years. In an earlier review by Esposito et al. 
(1998)87,88 on studies mainly reporting on threaded implants with a machined surface, i.e. 
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Branemark implants, the consensus was that smoking has a negative inﬂuence on implant 
survival. Furthermore, a comparison between threaded implants with machined and anodic-
oxidized surfaces showed no signiﬁcant inﬂuence of smoking on implant failures for implants 
with an anodic-oxidized surface.142 However, it is probably worth noting that studies including 
more modern implants with micro-structured surfaces like sand blasted and/or acid etched 
surfaces were scarcely published at that time. In the author’s opinion, whether these implant 
surfaces indeed signiﬁcantly improve outcomes in smokers need to be further explored through 
studies with larger sample sizes reporting data on implant failure rates in relation to smokers and 
non-smokers. The ﬁndings reported by Strietzel et al. (2007)156 considering the implant-related 
ORs for implant failures in smokers were remarkably similar to those published in another study 
by Hinode et al. (2006)42 who performed a meta-analysis on the effect of smoking on 
osseointegrated dental implants, based on implant-related data. This review used a subgroup 
analysis to examine success in the maxilla versus the mandible. Whereas the overall OR for 
implant failure was 2.17 (95% CI, 1.67–2.83), the OR in the maxilla was 2.06 (95% CI, 1.61–
2.65) and in the mandible was 1.32 (95% CI, 0.72–2.40), meaning the odds of failure was double 
in the maxilla, but statistically insignificant in the mandible. These two systematic reviews 
represent a small but growing body of evidence indicating implant failure risk is higher in 
smokers than in nonsmokers, particularly in the maxilla. In a systematic review by Berglundh et 
al. (2002)73 analyzing longitudinal studies of up to 5 years, implant survival rate of 97.5% up to 
the second stage surgery was observed. In the same year, Davarpanah et al.85 reported a survival 
rate of 96.5% for 1583 implants placed in different regions of the maxilla and mandible, with a 
follow-up period of 5 years as well. These results demonstrated a reduction in dental implant 
survival rate over time during the follow-up period. Simonis et al. (2010)153 and Carlsson et al. 
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(2000)76 concluded that there was a larger number of implant losses and higher level of peri-
implant marginal bone loss in patients who were smokers. These conclusions are supported by 
numerous other studies that have analyzed the inﬂuence of tobacco smoking on the survival and 
success of dental implants.6,113,165 A systematic review by Moraschini et al. (2015)34 revealed a 
mean survival rate of 94.6% (SD 5.97%) for a total of 7711 implants, with a mean follow-up of 
13.4 years. A number of authors from the included studies concluded that bone resorption 
occurred and was more evident after the ﬁrst year of prosthetic loading, and in one study (Pikner 
et al. 2009)136 it was suggested that implants placed in the mandibular arch tend to present greater 
marginal bone resorption over the course of time. This review (Moraschini et al. 2015),34 based 
on the results of the included studies, presented a mean peri-implant marginal bone loss of 1.3 
mm (SD 0.84 mm), and the study that presented the highest mean bone resorption value of 2.67 
mm evaluated 316 implants under mandibular overdentures during 12 years of follow-up (van 
Steenberghe et al. 2001).163 The results of pertinent studies should be interpreted with caution 
due to the possible presence of uncontrolled confounding factors and the risk of bias. However, 
the overall results of most of the recently published studies suggest that placement of dental 
implants in smokers affects MBL, the incidence of postoperative complications, as well as 
implant failure rates. In light of the findings of this review, smoking may be associated with 
significantly increased peri-implant MBL and implant failure rate. Exploring various preventive 
and interventional measures that can possibly limit the adverse effect of tobacco smoking on 
implant-related outcomes is highly recommended. Additionally, the potential adverse effects of 
smoking on treatment outcomes must be explained to the patient before treatment, and the 
dentists’ clinical decisions should be specific to each case. As the risk of implant failure is 
generally low, individual practitioners will have to decide what modifications to therapy, if any, 
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should be employed with their patients. In conclusion, smoking is a signiﬁcant risk factor for 
dental implant therapy. This should be clearly conveyed to the patient before treatment. A strict 
recall program throughout the course of the treatment to early detect negative changes in peri-
implant tissues or implant failure is necessary. 
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Background 
According to the 9th edition of the Glossary of Prosthodontic Terms,95 edentulism is defined as 
the state of being edentulous, i.e. without natural teeth. It is estimated that 178 million 
Americans are missing at least one tooth & about 40 million are completely edentulous (ACP).176 
The etiology of tooth loss is highly variable, ranging from tooth loss due to dental caries, 
periodontal disease, trauma or congenital anomalies. Tobacco smoking is a widely spread habit 
practiced all around the world. In 2016, an estimated 15.5% (37.8 million) of U.S. adults were 
current cigarette smokers. Of these, 76.1% smoked every day.44 Tobacco smoking is related to 
many health risks. It affects general and oral health causing increased risk of periodontal disease, 
dental caries, oral neoplasms and delayed wound healing. It was reported that there is an 
association between cigarette smoking and dental implant failure.3 The adverse effects of 
smoking and nicotine on oral soft tissue have also been observed in less-successful regenerative 
procedures and more gingival recession.138 Higher plaque index (PI) and increased probing depth 
(PD) have been reported in smokers compared to non-smokers.25 Furthermore, a 5-year 
retrospective study comparing different dental implants revealed that smokers have more 
marginal bone loss (MBL) around implants than non-smokers.16 
 
Description of the intervention 
The endosteal dental implant: a device placed into the alveolar and/or basal bone of the mandible 
or maxilla and transecting only one cortical plate.95 It is the most widely used dental implant type 
in contemporary dentistry. It is composed of an anchorage component, termed the fixture, which, 
ideally, is within the bone, a retentive component, termed the abutment and a restorative 
component in the form of a fixed, removable, or fixed-removable implant supported restoration 
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replacing single or multiple missing teeth and/or associated tissues. Dental implant survival 
refers to a dental implant that reside in placement site in the dental arch at the time of evaluation, 
regardless of any disease signs, symptoms, or history of problems. Dental implant success is 
usually defined by a set of criteria evaluating the condition and function of the implant at the 
time of evaluation, i.e. whether or not the implant satisfies the functional & esthetic demands. 
Dental implant failure often refers to loss of osseointegration and implant mobility that warrants 
removal of the implant. 
 
How this intervention might work 
Brånemark’s pioneering work on the phenomenon of osseointegration revolutionized the dental 
implants practice. Osseointegration is the concept that made dental implant therapy possible. It is 
defined as the direct structural and functional bone-to-implant contact. Successful 
osseointegration involves a series of biological events that includes inflammation, bone 
formation and remodeling.90 Missing tooth/teeth replacement with dental implants represents an 
invaluable treatment modality in modern dentistry and can preserve healthy natural teeth 
structure in cases of partial edentulism. 
 
Why it is important to do this review 
Although dental implant therapy is considered a predictable treatment modality with reported 
high survival and success rates, biological complications do occur and a number of risk factors 
have been involved, including the patient’s medical history, smoking habits, jawbone quality, 
radiation therapy, parafunctional habits, surgeon’s experience and susceptibility to periodontitis. 
The underlying mechanisms of the detrimental effects of smoking have been studied in vitro and 
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in vivo in animal and human studies. In vitro studies indicated that nicotine, a component in 
tobacco smoke, has a negative effect on the osteogenic gene expression in osteoblast cell lines.145 
Furthermore, nicotine combined with bacterial lipopolysaccharide (LPS) has been shown to 
stimulate the formation of osteoclast-like cells.157 Animal experiments have demonstrated that 
nicotine attenuates the expression of a wide range of factors involved in the osteogenic 
differentiation and formation of extracellular matrix and blood vessels.171 Additionally, smoking 
reduces the vascularization of the gingival tissues, impedes the immune response, and promotes 
a more pathogenic or “dysbiotic” oral microflora.112 Although the available evidence highlights 
the potential biological components affected by smoking, the exact mechanism behind the 
greater marginal bone loss (MBL) and the higher incidence of implant failure in smokers are not 
fully understood & need further investigation. Although not an absolute contraindication per se, 
smoking is considered a risk factor for dental implant failure. Several recommendations were 
suggested to enhance implant survival in smokers.45 However, despite the plethora of the current 
available literature, confounding factors and inconsistency in reported outcome measures & 
implant success criteria is not uncommon. 
 
Objectives 
The aim of this systematic review and meta-analysis is to test the null hypothesis of no difference 
in dental implant failure rates and marginal bone loss between smokers and non-smokers with 
regards to follow-up time. 
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Materials and methods 
The methodology of this review was adapted from the PRISMA statement (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses).118 The focus question was stated and 
categorized according to the PICO format (Population, Intervention, Comparison, and Outcome). 
Criteria for considering studies for this review 
This review sought prospective and retrospective cohort studies, as well as randomized & non-
randomized clinical trials that compared implant failure rates and peri-implant marginal bone 
loss between smokers and non-smokers. In this review, implant failure was regarded as the total 
loss of the implant. Only studies published in English were eligible for inclusion. 
Types of participants 
Study participants are adult subjects, with a minimum age of eighteen years or older, that are 
tobacco smokers and non-smokers who are fully or partially edentulous and received dental 
implant(s) re-habilitation to overcome problems with conventional removable complete or partial 
dentures or for providing alternative treatment options for fixed or fixed-removable implant-
supported restorations.  
Types of intervention 
Surgical placement of a single or multiple titanium endosseous dental implant(s) in one or both 
jaws to replace a single missing tooth or multiple missing teeth. 
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Types of outcome measures 
The outcome measures investigated in this review are the number of failed implants, comprising 
the dichotomous or binary outcome variable, and the amount of peri-implant marginal bone loss, 
as a continuous outcome variable, in smokers & non-smokers. 
Exclusion criteria: 
Letters to the editor, animal studies, in vitro studies, case series, case reports, commentaries and 
reviews were all excluded. In addition, articles that did not separately report outcome measures 
for smokers and non-smokers, included patients with congenital/familial medical conditions or 
uncontrolled autoimmune or systemic diseases or unbalanced metabolic disorders, included 
subjects with periodontal disease without prior treatment, or were poorly controlled for 
confounding variables were excluded. Lastly, any studies that did not obtain ethical approval or 
written informed consent, included fewer than 10 patients in each group, used short (<6 mm) or 
zygomatic implants or were not available online were also excluded.  
Search methods for identification of studies 
Electronic searches 
An extensive online search of the following databases was performed to locate relevant articles 
published up to June 2019: PubMed, Scopus, EBSCOhost Dentistry and Oral Sciences Source. 
To identify studies eligible for inclusion in this review, detailed search strategies were developed 
for each of the searched databases. These search terms were based on the search strategy 
originally developed for Medline (OVID) but revised appropriately for each database in an 
attempt to maximize the efficiency and effectiveness of the search and increase the number of 
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results. The search strategies incorporated a combination of MeSH (Medical Subject Heading) 
terms, controlled vocabulary and free text terms. The search strategies for each database are 
listed in Table 4. 
Searching other resources 
Citations and cross-referencing were comprehensively utilized to further the identification of 
studies and peer-reviewed dental journals were hand searched for possible related materials. In 
addition, grey literature was explored using Google Scholar and OpenGrey, until to June 2019. 
 
PICO question: Does smoking increase implant failure rate and peri-implant marginal bone 
loss in smokers compared to non-smokers? 
P: tobacco smokers and non-smokers who are fully or partially edentulous 
I: surgical placement of a single or multiple titanium endosseous dental implant(s) in one or both 
jaws to replace a single tooth or multiple missing teeth. 
C: comparison of outcome measures between smokers and non-smokers 
O: outcome measures of implant failure rate and the extent of peri-implant marginal bone loss 
Critical appraisal & assessment of risk of bias in the included studies 
The Cochrane collaboration's tool for assessing Risk of Bias (RoB) in randomized trials was 
utilized to assess randomized clinical trials.100 Quality assessment for non-randomized studies 
(prospective and retrospective cohort studies) was performed using the Newcastle–Ottawa scale 
(NOS).63 For the categories of ‘selection’ and ‘outcome’, studies may obtain a star/point for each 
item. For the ‘comparability’ category, two stars/points may be awarded. The highest score that 
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could be assigned to a study according to the NOS was nine stars/points (highest scientiﬁc 
evidence). Studies scoring six stars/points and above were considered to be of high quality. 
Data extraction 
Customized data extraction sheet were formulated and the following data were extracted from 
the included studies (when available): author(s) name(s), publication year, study type, follow-up 
period, number, gender and age of the subjects, smoking status & description, number & location 
of implants placed, implant brand, surface characterization, size & dimensions, healing period 
before loading, marginal bone loss in millimeters +/- standard deviation (SD), implant survival 
rate, number of failed and placed implants in smokers & non-smokers, P-value for implant 
failure rate, and the number of drop-outs. 
 
Dealing with missing data  
The original investigators were contacted by e-mail in cases of missing or unreported data. 
 
Statistical analysis 
Dichotomous and continuous variables from the included studies were analyzed through meta-
analysis when the same type of data was assessed by at least two studies. For binary outcomes, 
i.e. implant failure, the estimate of the intervention effect was expressed in the form of odds ratio 
(OR) with a conﬁdence interval (CI) of 95%. For continuous outcomes, i.e. marginal bone loss, 
the average and standard deviation (SD) were used to calculate the standardized mean difference 
(SMD) with a 95% CI. The results were pooled using the ﬁxed-effects model (Mantel–Haens-
zel–Peto test) or random-effects model (DerSimonian–Laird test). 
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Assessment of heterogeneity  
The I2 statistical test was used to express the percentage of heterogeneity in the studies. Values 
up to 25% were classiﬁed as indicating low heterogeneity, values of 50% as indicating medium 
heterogeneity, and values of ≥ 70% as indicating high heterogeneity. The results of the random-
effects model were validated when signiﬁcant heterogeneity was observed (P < 0.10). The ﬁxed-
effects model was considered when low heterogeneity was observed. The level of statistical 
signiﬁcance was set at P < 0.05. All data were analyzed using the Review Manager software; 
version 5.2.8 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 
Denmark; 2014). 
 
Publication bias 
Publication bias was explored graphically through a funnel plot. Asymmetry in the funnel plot 
may indicate possible publication bias. 
 
Results 
Literature search 
The electronic search yielded 379 titles from the selected databases. Additional 22 relevant 
articles were identified through other resources. After removal of duplicates, the records were 
screened by reading the title & abstract (& data tables when available). 30 articles were selected 
for full-text review. Seven studies were excluded (Table 3) after careful analysis, as they did not 
conform to the eligibility criteria of this review. Therefore, 23 studies; 3 RCTs and 20 
observational cohort studies published between 1993 and 2018 were included in the meta-
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analysis. The data search and selection process of studies are presented in Figure 1 as a 
PRISMA flow diagram. 
 
Fig 1: PRISMA flow diagram of the screening and article selection process. 
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Characteristics of the included studies 
Eight prospective and twelve retrospective cohort studies and three randomized clinical trials 
were included. The number of participants in the studies ranged from 32 to 1727 subjects, and 
the age range was 17 to 88 years. The follow-up period ranged from 6 to 240 months. The 
number of implants installed in smokers was 7124 and in non-smokers was 19226. The 
Branemark system (Nobel Biocare) was the most commonly used implant system. Five studies 
provided definitions for the smoking habits of the participants in terms of quantity or number of 
years of smoking, while only two studies did not provide definitions for the smoking habits of 
the patients investigated. Eleven studies reported a statistically signiﬁcant difference in the 
average number of implant failures between smokers and non-smokers. The difference was not 
statistically signiﬁcant in only one study. The characteristics of the included studies are presented 
in Table 1. 
  
Quality assessment 
The Cochrane RoB tool scores for corresponding randomized controlled trials were included in 
the forest plot (Figure 2) for the 3 included RCTs. For observational studies, only four studies 
obtained a score of less than six stars on the NOS. The scores for each study are summarized in 
Table 2.  
 
Marginal bone loss 
14 out of the 23 included studies reported on the analysis of marginal bone loss. All studies 
performed this analysis via standardized radiographic measurements from the implant platform 
to the alveolar bone crest. The marginal bone loss in the group of smokers ranged from 0.07 to 
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4.65 mm, while in the non-smoking group the marginal bone loss ranged from 0.04 to 3.13 mm. 
The analysis of marginal bone loss was performed using the random-effects model because of 
the high level of heterogeneity (I2 = 98%; P < 0.00001). A standardized mean difference (SMD) 
of 1.07 (95% CI 0.67–1.48) was found, demonstrating a statistically signiﬁcant difference in 
favor of non-smokers (P<0.00001). Four studies analyzed the marginal bone loss between 
maxillary and mandibular implants in smokers. Despite the high level of heterogeneity (I2 = 
97%; P = 0.00001), a SMD of 1.39 (95% CI 0.35–2.42) were observed, yielding a statistically 
signiﬁcant difference in favor of the mandible (P < 0.008). Figure 2 shows Forest plots for 
marginal bone loss in smokers compared to non-smokers and for MBL in maxilla versus 
mandible in the smokers’ group. 
 
Implant failure rate 
Thirteen studies reported on the number of implant failures in smokers versus non-smokers. The 
average survival rate of implants varied from 84.2% to 97% in the group of smokers, and from 
95.2% to 98.8% in the group of non-smokers. The results of the analysis of implant failure were 
classiﬁed into two subgroups according to the follow-up time, i.e. <5 years & >= 5 years. The 
ﬁxed-effects model was used for this analysis because of low heterogeneity (I2 = 34%; P < 
0.11). The total odds ratio was 2.24 (95% CI 1.90–2.64), demonstrating a statistically signiﬁcant 
difference in favor of the non-smoking group (P < 0.00001). The results for follow up subgroups 
differences demonstrated a signiﬁcant increase in implant failure with the increase in follow-up 
time (P = 0.05) although with considerable heterogeneity (I2=74.5%). The overall odds ratio for 
implant failure rate and the ORs for the subgroup analysis are shown in Figure 3. 
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Publication bias: Analysis of implant failure revealed symmetry of the funnel plot, therefore 
rejecting the possibility of publication bias (Figure 4). 
 
Discussion 
Tobacco smoking is an accepted potential risk factor for general and oral health. Investigating 
the causes of peri-implant marginal bone loss and implant failure is important for predictable 
implant therapy. Cigarette smoking has different adverse local and systemic effects. Local effects 
are mainly due to nicotine and cytotoxic vasoactive substances generated in the combustion of 
tobacco smoke. Systemically, cigarette smoking negatively affects the cellular immunologic 
response of neutrophils and production of antibodies. Smoking also influences bone metabolism 
and turn-over. If local absorption of cigarette smoke products had a definite influence on the 
failure of implants, this may explain the lower rates of mandibular implant failure in smokers as 
this area is possibly protected by the tongue and more salivary flow. Several clinical studies have 
shown that the survival of implants can be affected by tobacco smoking. The smoking habits 
assessed in this review are based on the patients' acknowledgment in the included studies. 
However, the quantity and frequency of smoking can be a key factor in determining the 
predictability of success in dental implants treatment. Only ﬁve studies included in this review 
deﬁned or classiﬁed smokers, this is a critical factor for risk assessment, but it’s often overlooked 
or under-reported. In a meta-analysis, homogeneity implies a mathematical compatibility 
between the results of each individual trial. Potential biases are likely to be greater for non-
randomized studies compared with RCTs, so results should always be interpreted with caution 
when they are included in reviews and meta-analyses. However, narrowing the inclusion criteria 
increases homogeneity but also excludes the results of more trials, and thus risks the exclusion of 
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signiﬁcant data.152 This was the reason to include non-randomized studies in the present meta-
analysis. This issue is important because meta-analyses are frequently conducted on a limited 
number of RCTs. In meta-analyses, such as these, adding more information from observational 
studies may aid in clinical reasoning and establish a more solid foundation for causal inferences. 
In the present meta-analysis, the statistical unit of analysis for ‘implant failure’ was the implant. 
It would be technically more correct to adjust for the effect of clustered, correlated observations; 
however, it is a challenging analytic method and the implant survival is so high that failing to 
adjust for clustered, correlated observations would have little effect on the estimate and deviation 
of survival.79 This systematic review attempted to identify studies comparing the marginal bone 
loss and implant failure rate between smokers and non-smokers. The search produced 
observational prospective and retrospective cohort studies and clinical trials. Despite the 
relatively small number of randomized controlled trials included, the inclusion of a large number 
of longitudinal observational studies, with large number of participants through a well-defined 
inclusion and exclusion criteria, in the meta-analysis can potentially increase the amount of 
information and consolidate the results from the clinical studies. Five different definitions in 
relation to smoking were reported by the studies, i.e. smoker and non-smoker, smoker and never 
smoker, low consumption and high consumption, mild smokers and heavy smoker, and one study 
defined smokers as individuals who smoked half a pack or more of cigarettes a day. The contrast 
in descriptions and definitions highlights these differences as potential confounding variable. 
Currently, there is no standardization in the classiﬁcation of patients regarding the number of 
cigarettes smoked per day. In addition, other confounding risk factors are known to inﬂuence the 
results by generating publication bias. There is still no consensus in the current evidence 
regarding the procedures that can minimize the risk of smoking on the health of dental implants. 
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Two-stage implant placement may decrease the physical contact with tobacco smoke and prevent 
the accumulation of bacterial bioﬁlms on the implant platform during the healing period, as it is 
already known that smoking patients tend to have greater bacterial bioﬁlm adhesion. Also, 
improving the gingival phenotype (increasing the area of keratinized mucosa) in the areas 
adjacent to implant sites would be a prudent measure. Because tobacco smoking can affect 
immune function, periodontally susceptible patients may be at a higher risk for dental implant 
complications, like increased amount of marginal bone loss and implant failure rates. However, a 
recent meta-analysis that evaluated the interaction between smoking and peri-implantitis 
concluded that there is low evidence implicating smoking as a risk factor for the development of 
peri-implant disease.150 There is a growing evidence in the literature indicating that tobacco 
smoke ingredients, as nicotine, may delay or inhibit healing after oral surgical procedures. The 
most accepted theory for the inﬂuence of smoking on healing in the oral tissues is the decrease in 
local blood ﬂow resulting from vasoconstriction, which causes changes in the cell population and 
the inﬂammatory process. Results of the present meta-analysis revealed that the marginal bone 
loss was signiﬁcantly higher in smokers compared to non-smokers (P < 0.00001). A comparison 
of the maxillary & mandibular arches revealed a significant difference favoring implants placed 
in the mandible. (P < 0.008). It is believed that the maxilla is more permeable to the effects of 
tobacco smoke possibly due to its increased medullary bone content and vascularity compared to 
the mandible. The bacterial plaque tends to adhere more quickly on the epithelial cells of 
smokers. This may cause an increase in the incidence of biological complications, such as peri-
implant mucositis and peri-implantitis and consequently an increase in the rate of peri-implant 
marginal bone loss. Limited number of clinical studies have compared implant marginal bone 
loss between smokers and non-smokers. Bain and Moy (1993)3 proposed that tobacco smoking 
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and decreased quality of available jawbone, could negatively affect healing and increase 
marginal bone loss, mainly in the maxillary arch. The current review analysis results for implant 
failure rate showed signiﬁcant increase in failure rate in smokers compared to non-smokers (P < 
0.00001). Additionally, the follow-up subgroups comparison revealed that implant failure rate 
increased with the increase in follow-up time (P = 0.05). However, considerable heterogeneity 
(I2=74.5%) was observed. 
 
Suggestions for future research 
A larger number of high-quality longitudinal studies, preferably be RCTs, with a follow-up 
period of at least 5 years evaluating the clinical performance of implants with emphasis on 
reporting outcomes for smokers and non-smokers individually, and possibly including implants 
with various surface characterizations and/or modifications, should be conducted in accordance 
with the guidelines available in the Consolidated Standards of Reporting Trials (CONSORT) 
statements.128 There should be standardization of the success criteria, thereby facilitating 
communication and comparison of the reported data. Aesthetics is a fundamental factor in dental 
implant therapy. In spite of this, no success criteria adopted by the studies in this review touched 
on the individual aesthetic criteria, such as the angle and positioning of the implants and the 
natural profile of peri-implant soft tissues. Aesthetic outcomes must be part of the evaluation of 
implant success. Lastly, with the growing popularity of electronic cigarettes and other similar 
devices, it might be worth-while looking into data generated by evaluation of dental implants 
placed in individuals who use these devices. 
 
 
 33 
Conclusion 
In light of the results of this review, tobacco smokers have a higher risk of biological dental 
implant complications compared to non-smokers. A statistically signiﬁcant difference (P < 
0.00001) in peri-implant marginal bone loss was found between the smoking group and the non-
smoking group, in favor of the non-smoking group with a standardized mean difference (SMD) 
of 1.07 (95% CI 0.67–1.48). Marginal bone loss in smokers was increased in the maxilla 
compared to the mandible with a SMD of 1.39 (95% CI 0.35–2.42) revealing a statistically 
signiﬁcant difference in favor of the mandible (P < 0.008). The total odds ratio for implant 
failure rate was 2.24 (95% CI 1.9–2.64), demonstrating a statistically signiﬁcant difference in 
favor of non-smokers (P < 0.00001). The results for follow up subgroups differences 
demonstrated a signiﬁcant increase in implant failure with the increase in follow-up time (P = 
0.05) although with considerable heterogeneity (I2=74.5%). Therefore, tobacco smoking patients 
must be encouraged to quit smoking or at least decrease consumption. Although causality 
between the measured parameters cannot be assessed with absolute certainty in observational 
studies, the outcomes of the current investigation indicate that there is a connection between 
tobacco smoking and increased peri-implant marginal bone loss and implant failure. So, for 
patients who actively smoke, as in other periodontal & oral surgical procedures, the clinical 
recommendation for a period of abstinence that at least covers the pre-surgical evaluation, initial 
therapy, definite implant treatment & immediate post-op phases remain to be very relevant. 
Therefore, taking into consideration the disparate outcome measures employed to assess dental 
implant performance and within the limitations of this systematic review, the null hypothesis is 
rejected, and the alternative hypothesis is accepted, which is in agreement with other related 
meta-analyses reported elsewhere in the literature.
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Author & 
year of 
publication 
Study type 
Follow-up 
period in 
months 
(mean or 
range) 
No. of 
subjects 
No. per 
group 
Age 
range 
Mean 
age 
Gender 
Smoking 
definition 
Number 
of 
implants 
& 
location 
Implant 
brand 
& 
Surface 
Implant 
dimensions 
Healing 
Period for 
loading 
(months) 
Marginal 
bone loss 
(mm) 
(mean +/- 
SD) 
Implant 
survival 
rate 
(%) 
Failed/placed 
implants 
in each 
group 
P-value
(for
implant 
failure 
rate) 
Drop-
outs 
Bain 1993 
Retrospective 
72 
540 
NR 
13–85 
55.1 
229 
M/311 
F 
Smoker and 
non-smoker 
2194 
Branemark 
Machined 
NR x 7,10, 
13,15,18,20 
6(maxilla) 
3(mandible) 
NR 
S:88.7 
NS:95.2 
S:44/390 
NS:86/1804 
<0.001 NR 
Haas 1996 
Retrospective 
Up to 108 
421 
S:107 
NS:314 
16–88 
53.1 
171 
M/250 
F 
Smoker and 
non-Smoker 
1366 
Branemark, 
Friatec 
Machined, 
rough 
NR 3 to 7 
S:2.7 +/-
1.87 
NS:1.58 
+/- 1.42 
NR 
NR/366 
NR/1000 
NR NR 
Lindquist 
1997 
Retrospective 
120 
45 
S:21 
NS: 24 
(33-64) 
M: 13 
F: 32 
Smoker and 
non-smoker 
266 Branemark NRx10 4 
S: 1.3+/-
0.55 
NS:0.65+/-
0.2 
NR 
S:NR/125 
NS:2/139 
<0.001 1 
Kumar 2002 
Prospective 
18 
461 
S:72 
NS: 389 
NR 
NR 
NR 
Smoker 
consisted of 
patients who 
smoked half a 
pack or more 
cigarettes a 
day 
1183 
Straumann 
Rough 
NR 1 to 3 NR 
S:97 
NS:98.3 
S:8/269 
NS:15/914 
<0.05 NR 
Schwartz-
Arad 2002 
Prospective 
36 
261 
S:89 
NS: 172 
18–67 
48 
NR 
Non-smokers; 
mild smokers 
(upto10 
cigarettes/day); 
heavy smokers 
(>10 
cigarettes/ day) 
959 
NR 
NR 
NR NR NR 
S:96 
NS:98 
S:15/380 
 NS: 12/579 
<0.05 NR 
Wennstrom 
2004 
RCT 
52 
S: 17 
NS: 34 
NR 
59.5 
NR 
Smoker and 
non-smoker 
149 
S: NR 
NS: NR 
Astra Tech 
(screw-
shaped,self-
tapping) 
NR NR 
S: 0.41 +/- 
0.69 
NS: 0.30 
+/- 0.84 
97.3 
S: NR 
NS: NR 
NR/50 
NR/99 
NR NR 
Table 1: characteristics of included studies
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Galindo-
Moreno 
2005 
Prospective 
185 
S: 63 
NS: 122 
NR 
49.77 
NR 
Smoker and 
non-smoker 
514 
S: NR 
NS: NR 
148press-
fit, 366 
screw type 
NR NR 
S: 0.45 +/- 
0.18 
NS: 0.42 
+/- 0.12 
NR 
S: NR 
NS: NR 
S: 175 
NS: 339 
NR NR 
Nitzan 2005 
Prospective 
9.4-86.6 
(mean 45.5) 
161 
S:59 
NS: 102 
23–89 
57 
NR 
Non-smokers; 
mild smokers 
(upto10 
cigarettes/day); 
heavy smokers 
(>10 
cigarettes/ day) 
646 
NR 
NR 
NR NR 
S:0.15 +/- 
0.09 
NS: 0.04 
+/- 0.04 
NR 
NR 
S:NR/271 
NS:NR/375 
NR NR 
DeLuca 
2006 
Prospective 
cohort 
389 
S: 285 
NS: 104 
NR 
49.3 
NR 
Smoker and 
non-smoker 
1330 
S: 285 
NS: 
1045 
Branemark NR NR 
S: NR 
NS: NR 
95.79 
S: 
94.74 
NS: 
96.94 
S: 26/285 
NS: 32/1045 
NR NR 
DeLuca & 
Zarb 2006 
Prospective 
Up to 240 
200 
S:54 
S:146 
15–77 
52.1 
NR 
Smoker and 
non-smoker 
1539 
Branemark 
Machined 
NR 
6(maxilla) 
3(mandible) 
S:0.07 +/- 
0.26 
NS:0.04 
+/-0.12 
NR 
NR 
NR/494 
NR/1045 
NR NR 
Herzberg 
2006 
Prospective 
cohort 
56.5 
60 
S: 21 
NS: 39 
NR 
52 
NR 
Smoker and 
non-Smoker 
212 
S: NR 
NS: NR 
Screw type NR NR 
S: 0.24 +/- 
0.49 
NS: 0.09 
+/- 0.32 
95.5 
S: 91 
NS: 
96.15 
S: 5/56 
NS: 4/104 
NR NR 
Sanchez-
Perez 2007 
Retrospective 
60 
66 
S:40 
NS:26 
15–71 
43.4 
NR 
Non-smokers; 
light smokers 
(<10 
cigarettes/ 
day); moderate 
smokers (10–
20 
cigarettes/day); 
heavy smokers 
(>20 
cigarettes/day) 
165 
Biotech 
Rough 
NR NR 
S:2.41 +/- 
1.46 
NS:3.13 
+/- 1.59 
S:84.2 
NS:98.6 
S:15/95 
NS:1/70 
<0.001 NR 
Sverzut 
2008 
Retrospective 
8 
650 
S:76 
S: 574 
13–84 
42.7 
NR 
Smoker and 
non-smoker 
1628 NR NR NR NR 
S:96.6 
NS:97.1 
S:7/197 
NS:43/1431 
0.5994 NR 
Anner 2010 
Retrospective 
1-114
475 
S:63 
51.96+/-
11.98 
NR 
1626 
NR 
NR NR NR NR NR 
S: 21/226 
NS: 56/1400 
0.0006 17 
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NS:412 M:176 
F: 299 
Cavalcanti 
2011 
Retrospective 
60 
1727 
S:549 
NS:1178 
17–85 
49.2 
M:702 
F:1025 
Smoker and 
non-smoker 
5843 
3i, 
AstraTech, 
Camlog, 
Friadent- 
Dentsply, 
Nobel 
Biocare, 
Straumann, 
Sweden and 
Martina, 
Zimmer 
Rough 
NR 0-9 NR 
S:94.5 
NS:97.1 
S:107/1961 
NS:112/3882 
0.003 250 
Rodriguez-
Argueta 
2011 
Retrospective 
6 minmum 
295 
S:113 
NS: 182 
21-68
53.1+/-
12.5 
M:127 
F: 168 
NR 1033 
Nobel 
Biocare 
Impladent 
Astratech 
(Rough 
surface) 
NR NR NR NR 
S: 14/389 
NS: 18/644 
NR 0 
Vandeweghe 
2011 
Retrospective 
60 
329 
S:41 
NS:288 
18–84 
54 
M:141 
F:188 
Smoker and 
non-smoker 
712 
Southern 
Implants 
Rough 
3.5, 
3.75,4,4.3, 
5, 6x8.5, 
10,10.5, 
11.5, 
12,13,13.5, 
15, 16.5,18 
NR 
S:1.56+/- 
0.53 
NS:1.32+/-
0.38 
S:95.2 
NS:98.8 
S: 5/104 
NS: 7/608 
0.007 NR 
Stoker 2012 
RCT 
99.6 
94 
S: 35 
NS:59 
59.8 
M: 28 
F: 66 
Smoker & 
never smoker 
256 
ITI/Bonefit 
dental 
implants 
TPS 
NR 3 
S: 1.72+/-
1.65 
NS: 
0.92+/-0.8 
96.5% 
10/256 
S:NR/96 
NS:NR/160 
NR 16 
Vervaeke 
2012 
Retrospective 
24 
300 
S:65 
NS:235 
17–82 
56 
M:114 
F:186 
Smoker and 
non-smoker 
1093 
NR 
NR 
3.5, 
4,4.5,5x8, 
9, 
11,13,15,17 
NR 
S:0.53+/-
0.92 
NS:0.29+/-
0.54 
S:96.7 
NS:98.7 
S:8/244 
NS:11/849 
0.025 0 
Sayardoust 
2013 
Retrospective 
60 
80 
S: 40 
NS:40 
NR 57.6 
M:38 M 
F:42 
Smoker and 
non-smoker 
80 
Branemark; 
Nobel 
Biocare 
Rough 
NR 3 to 4 
S: 1.39+/-
1.57 
NS: 
1.01+/- 
1.09 
S:89.6 
NS:96.9 
S:4/40 
NS:1/40 
<0.05 0 
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Cha 2014 
Prospective 
cohort 
161 
S: 18 
NS: 143 
NR 
Smoker and 
non-smoker 
462 
S: 48 
NS: 414 
Implatinium NR NR NR 
96.53 
S: 85.42 
NS: 
97.83 
S: 7/48 
NS: 9/414 
NR NR 
Sayardoust 
2017b 
RCT 
3 
32 
S:16 
NS:16 
61.8 
M:17 
F: 15 
Smokers: an 
average of>10 
cigarettes/day 
for>10 years & 
non-smokers 
96 
Max:67 
Mand: 
29 
Brånemark, 
Nobel 
Biocare 
Machined, 
oxidized, & 
laser-
modified 
NR 3 
S: 2.5+/-
0.11 
NS: 2.1+/-
0.06 
NR 
S: NR/48 
NS: NR/48 NR 0 
Al-Aali 
2018 
Retrospective 
60 
56 
S: 29 
NS: 27 
35-51
45
NR
Smoker & 
never smoker 
177 
Max:100 
Mand:77 
NR 
Rough 
4.1x10-14 NR 
S: 4.65+/-
0.68 
NS: 1.8+/-
0.33 
NR 
S:NR/86 
NS:NR/91 
NR 0 
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Selection 
Comparability 
of cohorts on 
the basis of the 
design or 
analysis 
Outcome 
Authors (Years) 
Representativ
-eness
of the exposed 
cohort 
Selection 
of the 
non-
exposed 
cohort 
Ascertainment 
of exposure 
Outcome 
of 
interest 
not 
present 
at start 
Assessment 
of outcome 
Was 
follow-up 
long 
enough 
for 
outcomes 
to occur? 
Adequacy of 
follow-up 
of cohorts 
Total 
9/9 
Bain (1993) 0 * * * *0 * * 0 6/9 
Haas (1996) 0 * * * *0 * * 0 6/9 
Lindquist (1997) * * * * *0 * * 0 6/9 
Kumar (2002) 0 * * * *0 * 0 0 5/9 
Schwartz-Arad (2002) 0 * * * *0 * * 0 6/9 
Galindo-Moreno (2005) * * * * *0 * 0 0 6/9 
Nitzan (2005) 0 * * * *0 * * 0 6/9 
DeLuca (2006) 0 * * * *0 * * 0 6/9 
DeLuca & Zarb (2006) 0 * * * *0 * * 0 6/9 
Herzberg (2006) * 0 * * *0 * * 0 6/9 
Sanchez-Perez (2007) * * * * ** * * 0 8/9 
Sverzut (2008) 0 * * * *0 * 0 0 5/9 
Anner (2010) * 0 * * ** * * * 8/9 
Cavalcanti (2011) * * * * *0 * * * 8/9 
Rodriguez-Argueta(2011) 0 0 * * *0 * 0 * 5/9 
Vandeweghe (2011) 0 * * * ** * * 0 7/9 
Vervaeke (2012) 0 * * * ** * * 0 7/9 
Sayardoust (2013) 0 * * * ** * * 0 7/9 
Cha (2014) * * * * *0 * 0 * 7/9 
Al-Aali (2018) 0 0 * * *0 * 0 0 4/9 
Table 2: Newcastle-Ottawa Scale quality assessment for cohort studies
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Fig 5: Funnel plot for the studies reporting the outcome measure: implant failure rate. 
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Characteristics of excluded studies 
Author (year): Title Type Reason for exclusion 
Aglietta (2010): A 10-year 
retrospective analysis of marginal 
bone-level changes around 
implants in periodontally healthy 
and periodontally compromised 
tobacco smokers  
Retrospective Did not individually report MBL levels or the total 
number of failed/placed implants at the end of the 
follow up period and how many were placed in 
smokers and non-smokers. 
Al Amri (2017): Comparison of 
Peri-Implant Soft Tissue 
Parameters and Crestal Bone Loss 
Around Immediately Loaded and 
Delayed Loaded Implants in 
Smokers and Non- Smokers: 5-
Year Follow-Up Results 
 
 
Retrospective 
Standard deviation for the mean total CBL (crestal 
bone loss) for smokers and non-smokers is not 
reported. Though can be estimated through some 
calculations, its usually inaccurate and can increase 
heterogeneity in the results. The total number of 
failed/placed implants at the end of the follow up 
period and how many were placed in smokers and 
non-smokers are not reported. Attempted to contact 
the corresponding author by e-mail but received no 
reply. 
Ata-Ali (2016): Impact of heavy 
smoking on the clinical, 
microbiological and 
immunological parameters of 
patients with dental implants: a 
prospective cross-sectional study 
Prospective 
Did not individually report MBL levels or the 
number of failed/placed implants in smokers versus 
non-smokers. Microbiological sampling of the peri-
implant sulcus fluid is the main focus of the study. 
Balshe (2008): The effects of 
smoking on the survival of smooth 
and rough surface dental implants 
Retrospective 
Did not individually report MBL levels or the 
number of failed/placed implants in smokers versus 
non-smokers. The study focused on smooth versus 
rough implant surface comparison. 
Baqain (2012): Early dental 
implant failure: risk factors 
Prospective 
Of the 15/399 failed/placed implants, the study did 
not report how many were placed in smokers and 
non-smokers. Attempted to contact the 
corresponding author by e-mail but received no 
reply. 
Sun (2016): Effect of Heavy 
Smoking on Dental Implants 
Placed in Male Patients Posterior 
Mandibles: A Prospective Clinical 
Study 
Prospective 
The distribution of the implants placed (n=45) 
among the heavy smokers and non-smokers is not 
reported. Also, the study evaluated only 1 implant 
per patient. The osteogenic jaw bone sampling is 
the main focus of the study. 
Uribarri (2017): Bone 
Remodeling around Implants 
Placed in Augmented Sinuses in 
Patients with and without History 
of Periodontitis  
Prospective 
The total number of failed/placed implants at the 
end of the follow up period and how many were 
placed in smokers and non-smokers are not 
reported. The MEAN MBL+/- SD in smokers and 
non-smokers at the end of the follow up period is 
not reported. Attempted to contact the 
corresponding author by e-mail but received no 
reply. 
Table 3: excluded studies and reason(s) for exclusion. 
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Search strategies 
PubMed Results 
(((((((jaw, edentulous[MeSH Terms]) OR jaw, edentulous, partially[MeSH Terms]) 
OR smoking[MeSH Terms]) OR cigarette smoking[MeSH Terms])) AND ((((((dental 
implant[MeSH Terms]) OR dental implants[MeSH Terms]) OR dental 
implantation[MeSH Terms]) OR dental implantation, endosseous[MeSH Terms]) OR 
endosseous dental implantation[MeSH Terms]) OR osseointegrated dental 
implantation[MeSH Terms])) AND ((smokers) OR nonsmokers)) AND ((((((((((((bone 
resorption[MeSH Terms]) OR dental implant bone resorption) OR alveolar bone 
loss[MeSH Terms]) OR marginal bone loss) OR dental implant bone loss) OR 
periodontal pocket[MeSH Terms]) OR dental implant probing depth) OR peri-implant 
probing depth) OR peri-implant tissue health) OR survival rates[MeSH Terms]) OR 
cumulative survival rates[MeSH Terms]) OR dental implant survival) 
150 
Scopus Results 
Smoking OR cigarette smoking AND dental implants OR dental implantation OR 
endosseous dental implants OR osseointegrated dental implants AND marginal bone 
loss OR bone resorption OR dental implant bone resorption or dental implant bone 
loss or dental implant probing depth or peri-implant bone loss 
40 
EBSCOhost Dentistry & Oral Sciences Results 
Smoking AND dental implant complications OR marginal bone loss OR implant 
failure rate 
189 
379 Total 
Table 4: the final Boolean search keywords utilized in different electronic databases. Last search 
update June 1st, 2019. 
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